ANTERIS
LIVE

Serial Number

88605333

Owner

Anteris Technologies Ltd.

Attorney

John P. McCormick

First Use Date

Jul 25, 2023

Filing Date

Sep 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ANTERIS Trademark

Serial Number: 88605333 • Registration: 7422294

ANTERIS is a trademark filed by Anteris Technologies Ltd. on September 5, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Anteris Technologies Ltd. (4 trademarks)

9 Sherwood RdToowong QLD 4066

Entity Type: 03

Admedus Ltd (6 trademarks)

Level 1, 197 Adelaide Terrace

Entity Type: 99

Trademark Details

Filing Date

September 5, 2019

Registration Date

June 18, 2024

First Use Anywhere

July 25, 2023

First Use in Commerce

July 25, 2023

Published for Opposition

June 30, 2020

Goods & Services

Engineered biological tissue for use in cardiovascular repair, soft tissue repair, hernia repair, regenerative medicine and other medical purposes; Biological tissue grafts; implants comprising living tissue; surgical implants comprising living tissue; biological tissue grafts, implantable scaffolds, and tissue cultures for medical and veterinary purposes; medical preparations for the regeneration of tissue; surgical, medical, and veterinary products and preparations, namely, preparations used for use in cardiovascular surgery and for treating cardio and vascular defects; sanitary preparations for medical purposes; natural biomaterials for augmentation of tissue for medical purposes; prepared collagenous biological tissue intended for subsequent grafting, transplantation and tissue support; medical preparations for the treatment, reconstruction, re-contouring and repair of tissue and cardiac structure

Surgical implants comprising artificial material; Surgical implants comprising artificial material and associated surgical instrument sets; Surgical instruments and apparatus; Medical apparatus and instruments for treating cardiovascular disease; medical products, namely, cardiovascular devices in the nature of heart valves, valve leaflets, catheters, stents, and other medical apparatus and instruments for the treatment of cardiovascular disease; medical devices, namely, artificial heart valves and heart valve delivery catheters; Bioprosthetic heart valves; transcatheter delivery systems for prosthetic heart valves and leaflets for cardiovascular repair; catheter delivery systems for prosthetic heart valves and leaflets for cardiovascular repair

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 18, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 18, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 14, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 14, 2024 CNPR
ASSIGNED TO EXAMINER
May 13, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 11, 2024 CRFA
ASSIGNED TO LIE
Apr 11, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Aug 21, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Aug 14, 2023 SUPC
USE AMENDMENT FILED
Aug 9, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 9, 2023 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 8, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 8, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 8, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 8, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 8, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 8, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 10, 2023 EXRA
SOU EXTENSION 5 GRANTED
Mar 9, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 9, 2023 AITU
SOU EXTENSION 5 FILED
Feb 24, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 24, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 26, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 24, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 24, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 24, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 26, 2022 EXRA
SOU EXTENSION 3 GRANTED
Feb 24, 2022 EX3G
SOU EXTENSION 3 FILED
Feb 24, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 24, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 26, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 24, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 24, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 24, 2021 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 22, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 22, 2021 REAP
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 3, 2021 ASCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2021 EXRA
SOU EXTENSION 1 GRANTED
Feb 25, 2021 EX1G
SOU EXTENSION 1 FILED
Feb 25, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 25, 2021 EEXT
REVIEW OF CORRESPONDENCE COMPLETE
Aug 27, 2020 CORV
ASSIGNED TO PETITION STAFF
Aug 26, 2020 APET
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 25, 2020 NOAM
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 22, 2020 ASGN
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 9, 2020 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 25, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 13, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 10, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 10, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 10, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 8, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2019 NWOS
NEW APPLICATION ENTERED
Sep 9, 2019 NWAP